Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin - PubMed (original) (raw)

Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin

S Shaikh et al. Lett Appl Microbiol. 2016 May.

Abstract

Bacterial pathogens producing CTX-M beta-lactamases are emerging around the world as a source of resistance to oxyimino cephalosporins such as cefotaxime. In this study, we have investigated the prevalence of blaCTX-M genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae. Of the double-disk synergy test-positive E. coli (n = 94) and Kl. pneumoniae (n = 73) strains isolated during the study period, 41 (44·08%) E. coli and 32 (43·24%) Kl. pneumoniae isolates were found to be positive for blaCTX-M genes. Twenty-two integrons (13 for E. coli and 9 for Kl. pneumoniae) were detected whose sizes ranged from 600 bp to 1·5 kb. All these integrons were found to be of Class1 type and were invariably PCR positive for int1 and sul1 genes. Marker transfer experiments demonstrated plasmid-mediated transfer of cefotaxime and ceftazidime resistance markers. In addition, analysis of the enterobacterial repetitive intergenic consensus (ERIC)-PCR typing of the blaCTX-M -carrying isolates showed that they were genetically diverse and heterogeneous suggesting that multiple subtypes of the species were involved in infection.

Significance and impact of the study: A high frequency of blaCTX-M -resistant marker has been found in Escherichia coli and Klebsiella pneumoniae isolates of clinical origin. Analysis of the ERIC-PCR typing of the blaCTX-M -carrying isolates showed that they were genetically diverse and heterogeneous suggesting that multiple subtypes of the species were involved in infection.

Keywords: CTX-M beta-lactamases; Class 1 integrons; ERIC-PCR; Escherichia coli; Klebsiella pneumoniae; genotypic method.

PubMed Disclaimer

Cited by

Gold Nanoparticle-Based Resuscitation of Cefoxitin against Clinical Pathogens: A Nano-Antibiotic Strategy to Overcome Resistance.
Alafnan A, Rizvi SMD, Alshammari AS, Faiyaz SSM, Lila ASA, Katamesh AA, Khafagy ES, Alotaibi HF, Ahmed ABF. Alafnan A, et al. Nanomaterials (Basel). 2022 Oct 18;12(20):3643. doi: 10.3390/nano12203643. Nanomaterials (Basel). 2022. PMID: 36296833 Free PMC article.
Effect of rifampicin combination-regimens against multi-drug resistant strains in North India.
Rafeeq MM, Habib AH, Alzamami A, Alturki NA, Mashraqi MM, Alghamdi YS, Alshamrani S, Alharthi AA, Ahmad S. Rafeeq MM, et al. Bioinformation. 2022 May 31;18(5):482-487. doi: 10.6026/97320630018482. eCollection 2022. Bioinformation. 2022. PMID: 36945223 Free PMC article.
Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt.
Elmonir W, Abd El-Aziz NK, Tartor YH, Moustafa SM, Abo Remela EM, Eissa R, Saad HA, Tawab AA. Elmonir W, et al. Biology (Basel). 2021 Apr 26;10(5):373. doi: 10.3390/biology10050373. Biology (Basel). 2021. PMID: 33926062 Free PMC article.
Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance.
Shaikh S, Nazam N, Rizvi SMD, Ahmad K, Baig MH, Lee EJ, Choi I. Shaikh S, et al. Int J Mol Sci. 2019 May 18;20(10):2468. doi: 10.3390/ijms20102468. Int J Mol Sci. 2019. PMID: 31109079 Free PMC article. Review.

Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin - PubMed (original) (raw)